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Protective Activity of Aromatic Amines and Imines
against Oxidative Nerve Cell Death
Introduction
The occurrence of oxidative damage and an increased
oxidative burden from free radical species appears to
represent a recurrent hallmark of diverse neurodegenera-
tive and neurological disorders (Simonian and Coyle,
1996). There is evidence that oxidative stress may consti-
tute an essential part of the pathogenetic process, for ex-
ample, in Alzheimer’s disease (Multhaup et al., 1998;
Behl, 1999; Christen, 2000), Parkinson’s disease (Ebadi
et al., 1996; Foley and Riederer, 2000), Huntington’s dis-
ease (Browne et al., 1999), amyotrophic lateral sclerosis
(Cookson and Shaw, 1999; Gurney, 2000), multiple scle-
rosis and other demyelinating diseases (Smith et al.,
1999), cerebellar ataxias such as ataxia telangiectasia
and Friedreich’s ataxia (Kamsler et al., 2001; Palau,
2001), HIV neuropathy (Kaul et al., 2001), and prion dis-
eases (Milhavet et al., 2000; Wong et al., 2000).
Neuronal cell dysfunction and cell death due to oxida-
tive stress may causally contribute to the pathogeneses
of these progressive diseases, but increased levels of
free radical species also appear to be involved in more
acute syndromes of neurodegeneration, such as neuro-
trauma, cerebral hemorrhage, and reperfusion injury after
ischemic events (Dirnagl et al., 1999; Love, 1999; Parn-
ham and Sies, 2000).
As a result of this widespread involvement of oxidative
stress in neuronal dysfunction and the associated neuro-
logical disorders, the conclusion has been drawn that
central, but also peripheral, nervous system cells are par-
ticularly vulnerable to oxidative imbalances, which might
be a direct consequence of their unique topological ar-
chitecture and the biochemical substrata they are built of
(Floyd, 1999; Moosmann and Behl, 2000a; Shaw and
Eggett, 2000). Consequently, neuroprotective antioxi-
dants are being considered as a promising approach to
slow down disease progression and to limit the extent of
functional neuronal loss in chronic neurodegenerative
disorders as well as after acute lesions of the brain.
To date, clinical evidence for a positive role of antioxi-
dants in neurological disease is relatively scarce (Parkin-
son Study Group, 1993; Louwerse et al., 1995; Sano et
al., 1997; Gutzmann and Hadler, 1998; Huntington Study
Group, 1998; Shoulson, 1998; Ogawa et al., 1999;
Grundman, 2000; Lodi et al., 2001; for a review, see
Moosmann and Behl, 2001). Several of the less success-
ful studies reported, however, may be readily explained
from methodological inconsistencies, e. g., the use of
compounds whose efficacy had not even been proven in
the established animal or in vitro models of the disease,
or from the administration of compounds with a rather
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Oxidative stress is a widespread phenomenon in the
pathology of neurodegenerative diseases such as
Alzheimer’s disease, Parkinson’s disease, and amy-
otrophic lateral sclerosis. Neuronal cell death due to
oxidative stress may causally contribute to the patho-
geneses of these diseases. Therefore, neuroprotec-
tive antioxidants are considered to be a promising ap-
proach to slow down disease progression. We have
investigated different aromatic amine and imine com-
pounds for neuroprotective antioxidant functions in
cell culture, and found that these compounds pos-
sess excellent cytoprotective potential in diverse par-
adigms of oxidative neuronal cell death, including
clonal cell lines, primary cerebellar neurons, and
organotypic hippocampal slice cultures. Aromatic
amines and imines are effective against oxidative glu-
tamate toxicity, glutathione depletion, and hydrogen
peroxide toxicity. Their mode of action as direct an-
tioxidants was experimentally confirmed by electron
spin resonance spectroscopy, cell-free brain lipid
peroxidation assays, and intracellular peroxide
measurements. With half-maximal effective concen-
trations of 20 – 75 nM in different neuroprotection ex-
periments, the aromatic imines phenothiazine, phe-
noxazine, and iminostilbene proved to be about two
orders of magnitude more effective than common
phenolic antioxidants. This remarkable efficacy could
be directly correlated to calculated properties of the
compounds by means of a novel, quantitative struc-
ture-activity relationship model. We conclude that
bridged bisarylimines with a single free NH-bond,
such as iminostilbene, are superior neuroprotective
antioxidants, and may be promising lead structures
for rational drug development.
Key words: Antioxidant /Cytoprotection /Free radical /
Neurodegeneration /Oxidative stress /Quantitative
structure-activity relationship (QSAR).
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unfavourable pharmacological profile, for example poor
permeation of the blood-brain barrier (Vatassery et al.,
1998; Grundman, 2000; Gilgun-Sherki et al., 2001; Moos-
mann and Behl, 2001). Nevertheless, results from stan-
dardized animal models, epidemiological studies, and
from a wide array of biochemical considerations seem to
indicate that certain investigational antioxidant com-
pounds might have a profound preventive or therapeutic
value (Sies, 1993; Baker et al., 1998; Parkes et al., 1998;
Reiter, 1998; Leppala et al., 1999; Nourhashemi et al.,
2000; Jung et al., 2001; and the above reviews). Conse-
quently, the search for antioxidant pharmaceuticals
which (i) inhibit pathogenetically relevant oxidative phe-
nomena, (ii) readily pass the blood-brain barrier, and (iii)
show a higher efficacy per dose, thereby concomitantly
exhibiting a reduced risk of adverse side effects, is in the
center of interest of clinically involved physicians as well
as biochemically focused scientists (Harman, 1996; Behl,
1999; Prasad et al., 1999; Alexi et al., 2000; Grunblatt et
al., 2000; Prasad et al., 2000; Sramek and Cutler, 2000;
Wolozin and Behl, 2000; Gilgun-Sherki et al., 2001).
By employing relevant models of oxidative neuronal
cell death, which have been successfully used in the as-
sessment and potency ranking of phenolic antioxidants
(Moosmann and Behl, 1999; Ishige et al., 2001), we have
investigated the potential antioxidant cytoprotective ef-
fects of diverse aromatic amine and imine compounds.
The pharmacological actions of the compounds are de-
scribed on the basis of different cell biological systems
(clonal cells lines, primary cell culture, and organotypic
slice cultures), and they are functionally rationalized by
effects exerted in biochemical and biophysical experi-
ments. Finally, a quantitative structure-activity relation-
ship model is presented, which directly links calculated
molecular properties of the compounds to their protec-
tive effects in neuronal cell systems.
Results
Aromatic Amines and Imines Protect Clonal and
Primary Neurons from Oxidative Cell Death
Several aromatic amines and imines, whose structures
are shown in Figure 1, were investigated for their poten-
tial antioxidant and cytoprotective properties. As repre-
sentative examples for the two classes of the amines and
imines, the compounds 4-dodecylaniline and iminostil-
bene were selected, respectively. Figure 2 illustrates the
potent neuroprotective effects of these compounds.
While 2.5 mM glutamate leads to a complete loss of cell
viability in the mouse hippocampal cell line HT22 via an
oxidative cell death cascade (Figure 2D, E), the concomi-
tant addition of 1 µM 4-dodecylaniline (Figure 2G, H) or
100 nM iminostilbene (Figure 2J, K) results in an almost
full prevention of the toxic effect, as assessed by phase
contrast microscopy and propidium iodide staining. A
similarly profound cytoprotective effect of the antioxidant
drugs can be observed in rat primary cerebellar neurons
(Figure 2, right column). These cells were set under ox-
idative stress by L-buthionine-[S,R]-sulfoximine (BSO)-
mediated inhibition of intracellular glutathione metabo-
lism, which leads to the loss of neuritic structures and the
disintegration of the cell bodies (Figure 2F versus C). Do-
decylaniline as well as iminostilbene prevent these ef-
fects of glutathione depletion (Figure 2I and L).
Organotypic Hippocampal Slice Cultures Are
Rendered Resistant to Oxidative Stress by 
4-Dodecylaniline and Iminostilbene
In order to test these results in a cellular model closer to
the in vivo situation, rat organotypic hippocampal slice
culture, a method that leaves differentiated cells within
their native connectivity patterns, was employed. Expo-
sure to hydrogen peroxide results in widespread neuronal
cell death among the cornu ammonis and the gyrus den-
tatus neurons of the hippocampus (Figure 3B versus A).
The presence of dodecylaniline (Figure 3C) or iminostil-
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Fig. 1 Chemical Structures of the Aromatic Amines and Imines
Used in This Study.
The aromatic amine and imine compounds that were investigat-
ed for neuroprotective activities are shown. The structures of
two phenolic compounds are included for comparison.
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bene (Figure 3D) completely protects these neurons from
the toxic effects of hydrogen peroxide overload.
Aromatic Amines and Imines Are Effective in Diverse
Cellular and Biochemical Systems, Counteract
Various Oxidative Stressors, and Show Highly
Reproducible Half-Maximal Effective Concentrations
A quantitative analysis of the antioxidant effects of dode-
cylaniline and iminostilbene, illustrating the pharmacolo-
gy and bandwidth of effect of these compounds, is shown
in Figure 4. The cytoprotective effects of the substances
against different toxins in HT22 cells are plotted in Figure
4A-D. The dose-response curves show that both com-
pounds not only protect the cells from glutamate toxicity
(Figure 4A), but also from the toxic effects of BSO (Figure
4B), hydrogen peroxide (Figure 4C), and tert-butyl hy-
droperoxide (Figure 4D). The half-maximal effective con-
centrations (EC50 values) of each compound are very sim-
ilar in all of these cases. The antioxidant cytoprotective
effects of dodecylaniline and iminostilbene are also de-
tectable in human neuronal cells (Figure 4E), peripheral fi-
broblasts (Figure 4F), and rat primary cerebellar neurons
(Figure 4G), as qualitatively depicted in Figure 2. Figure
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Fig. 2 Antioxidant Neuroprotection by Aromatic Amines and Imines in Clonal and Primary Cell Culture.
Dodecylaniline and iminostilbene protect clonal hippocampal cells from oxidative glutamate toxicity and primary neurons from intra-
cellular glutathione depletion. The left column shows phase contrast micrographs of mouse HT22 cells, the central column depicts flu-
orescence photographs of propidium iodide-stained cell cultures, corresponding to the cultures in the left column, and the right column
shows rat primary cerebellar neurons. The first row shows the untreated positive controls, the second row the corresponding negative
controls set under oxidative stress, and the third and fourth rows demonstrate the protective effects of 1 µM 4-dodecylaniline and 100
nM iminostilbene, respectively. 2.5 mM glutamate was employed as toxin for the HT22 cells in (D) and (E) and the pictures below, lead-
ing to almost complete cell death after 24 h. Cerebellar neurons were treated with 0.8 mM L-buthionine-[S,R]-sulfoximine (BSO) for 48
h, resulting in a collapse of the neurites and the lysis of the cell bodies (F). In both of these oxidative stress paradigms, dodecylaniline
(G-I) and iminostilbene (J-L) were able to revert the oxidative phenotype of the cells nearly to completion, as assessed by morphologi-
cal evaluation (in the left and right columns), specific staining procedures (in the central column), and metabolic assays (shown in Fig-
ure 3). The high efficacy of the bisarylimine antioxidant iminostilbene at a concentration of only 100 nM is particularly remarkable. The
photographs show areas of 200 × 300 µm.
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4H shows that both substances do not only rescue the
cells from oxidative cell death, but they also suppress,
during the preceding periods in the lethal oxidative cas-
cade, the intracellular accumulation of peroxides as in-
duced by BSO. Their antioxidant action therefore seems
to correspond to their cytoprotective effect in HT22 cells.
The idea that the compounds’ antioxidative efficacy is
due to a chemical structural activity is additionally sug-
gested by results shown in Figure 4I. A cell-free, native rat
brain lipid preparation is efficiently protected from peroxi-
dation reactions. The direct inhibition of free-radical chain
reactions, occuring during lipid peroxidation, may there-
fore be a major cause for the neuroprotective effects of
dodecylaniline and iminostilbene. This notion is finally
corroborated by kinetic experiments on glutamate toxici-
ty in HT22 cells. Figure 4J shows that both compounds
confer clear cytoprotection from glutamate toxicity even
when added several hours after the toxin. Iminostilbene
retains its full cytoprotective potential until approximately
8 hours after glutamate addition, which is immediately be-
fore cell membranes begin to lyse in the first cells. Dode-
cylaniline loses some of its protectivity before that time
point, possibly due to a slower penetration of the cells.
Nevertheless, when administered at that time point (– 8 h),
the half-maximal effective concentrations of the com-
pounds are not altered (Figure 4K), indicating an identical
mechanism of action at both time points 0 h (Figure 4A)
and – 8 h (Figure 4K). The similarly antioxidant nature of
the delayed protective action is demonstrated by the per-
oxide measurements in Figure 4L, which show that the
delayed addition of both compounds to cells which have
already accumulated increased levels of intracellular per-
oxides reduces this peroxide load significantly.
The dose-response curves in Figure 4 show that both
compounds exhibit a highly reproducible antioxidant and
cytoprotective behaviour, comprising many different cel-
lular oxidative stress paradigms. Therefore, the two mod-
el systems of Figure 4A (glutamate toxicity in murine
cells) and Figure 4E (peroxide toxicity in cells of human
origin) were chosen for determining the half-maximal ef-
fective concentrations (EC50 values) of all the compounds
depicted in Figure 1. These results are shown in Table 1.
The Free Nitrogen-Hydrogen (NH-) Bond Is Essential
for the Observed Cytoprotective Effects
All aromatic amines and imines with at least one free ni-
trogen-hydrogen (NH)-bond show some protective prop-
erties, with the less effective compounds exhibiting EC50
values between 1 and 10 µM, which is comparable to the
characteristics of the two phenolic control compounds.
Substances containing two aromatic ring systems,
whether separated or linked, show higher efficacies, with
the bridged compounds iminostilbene, phenoxazine and
phenothiazine having the highest potencies and the low-
est EC50 values of averaged 75, 45, and 20 nM, respec-
tively. Abrogation of the NH-bonds leads to a loss of cy-
toprotective activity, as exemplified by the relative
inefficiency of N,N-dimethyl-1-naphthylamine and N-
methyl-phenothiazine. Aromatic amines and imines
therefore seem to constitute a whole class of cytoprotec-
tive antioxidants.
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Fig. 3 Neuroprotective Effects of Aromatic Amines and Imines in Organotypic Hippocampal Slice Cultures.
After 72 h treatment with the oxidative neurotoxin hydrogen peroxide (500 µM), propidium iodide staining reveals pronounced cell death
in the gyrus dentatus (GD) and in the cornu ammonis (CA) regions of the hippocampus (B) as compared with untreated control cultures
(A). The presence of 4-dodecylaniline (10 µM; C) or iminostilbene (1 µM; D) completely prevent this effect of hydrogen peroxide in hip-
pocampal slice cultures. The photographs show areas of 2 × 3 mm.
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Fig. 4 Pharmacology and Bandwidth of Effect of the Two Compounds Dodecylaniline and Iminostilbene.
Dose-response curves of the antioxidant and cytoprotective effects of 4-dodecylaniline () and iminostilbene () in a variety of cell bi-
ological and biochemical paradigms. (A) Cytoprotective effect of dodecylaniline and iminostilbene in HT22 hippocampal cells chal-
lenged with glutamate (2 mM; 16 h). Both compounds significantly enhance cell viability of the neuronal cells under these toxic doses of
glutamate, administered comcomitantly with the latter. The half-maximal effective concentrations (EC50 values) for the protective effect
are, however, different for the two compounds, with a value of 70 nM for iminostilbene and 900 nM for dodecylaniline. The dashed line
indicates the cell viability of the control cells treated with toxin alone. Panel (B) shows the effects of dodecylaniline and iminostilbene in
HT22 cells depleted of intracellular glutathione by L-buthionine-[S,R]-sulfoximine (BSO) treatment (300 µM; 24 h); in (C) HT22 cells were
challenged with hydrogen peroxide (180 µM; 16 h); and in (D) the cells were incubated with tert-butyl hydroperoxide (30 µM; 16 h). Irre-
spective of the different oxidative toxins, both compounds exhibit pronounced cytoprotective effects with very similar EC50 values.
These can further be reproduced in human neuronal SK-N-MC cells (E) (hydrogen peroxide 160 µM; 16 h), mouse NIH3T3 fibroblasts (F)
(hydrogen peroxide 250 µM; 16 h), and in rat primary cerebellar neurons (G) (BSO 500 µM; 48 h). The inhibition of cell death in HT22 cells
is accompanied by a suppression of the pre-lethal intracellular accumulation of peroxides (H) as induced by BSO (1 mM; 8 h). Graph (I)
shows that both compounds also significantly suppress brain lipid peroxidation (induced by 50 µM ascorbate), with dose-response
curves strongly resembling the cytoprotection dose-response curves. A kinetic analysis of the protective effect of the two compounds
against glutamate toxicity (2 mM) in HT22 cells, with a delayed addition of the antioxidants (10 µM), reveals that both confer cytoprotec-
tion even when added several hours after the toxin (J). A dose-response analysis for this delayed protection at the time point – 8 h is giv-
en in (K). (L) shows the intracellular peroxide load of HT22 cells pretreated with glutamate for 8 h, followed by an additional incubation
with glutamate and the antioxidants for 2 h. This delayed addition of dodecylaniline and iminostilbene also leads to a significant reduc-
tion of the intracellular peroxide level.
In all cases, data are given as mean ± s.e.m. Cell viability data were measured according to the MTT method at least in triplicate as de-
scribed in Materials and Methods. The respective negative control cell viability is given as a dashed line. Concerning the biochemical
data (H,I,L), triplicate measurements were normalized to the corresponding positive and negative control values, which are indicated as
dotted 0% and 100% lines.
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Iminostilbene Is a Direct Spin Quencher in 
Organic Solvents
The inhibitory role of iminostilbene on free radical-medi-
ated reactions was also demonstrated by electron spin
resonance (ESR) spectroscopy, in order to verify the bio-
chemical results. Using ethanol as solvent, N-tert-butyl-
α-phenylnitrone (PBN) as a spin trap, and tert-butyl hy-
droperoxide as source of free radicals, iminostilbene
drastically suppressed the formation of ESR-detectable
PBN spin adducts (Figure 5). Even at a 500-fold lower
molar concentration compared to PBN, iminostilbene still
significantly quenches the nitrone paramagnetic signal
(Figure 5F). Iminostilbene therefore directly and efficient-
ly interacts with oxidizing free radical species.
The Antioxidant Cytoprotective Potential of Aromatic
Amines and Imines Can Be Predicted by Means of a
Quantitative Structure-Activity Relationship (QSAR)
In order to gain some insight into the structural causes for
the very different EC50 values of the tested compounds in
cell culture (Table 1), a number of structural properties of
the compounds were calculated by computational chem-
istry. A multiple linear regression analysis approach was
used to identify those physico-chemical properties that
are either directly correlated to or significantly influence
their cytoprotective potential (Table 2). The main parame-
ters to predict the protective potency of a compound
were found to be (i) the difference of the heats of forma-
tion (∆Hf) of a compound and its radical form, with a cor-
relation coefficient of r2 = 0.675, and (ii) the energy of this
radical’s lowest unoccupied molecular orbital [E(LUMOr);
r2 = 0.626]. The respective radicals were formed in silico
by the removal of a hydrogen atom at the functionally es-
sential aromatic nitrogen atom (Figure 1). A mathematical
combination of these two physico-chemical properties
leads to a bilinear model for cytoprotective antioxidant
action with an adjusted r2 value of 0.787 (equation 1 in the
Materials and Methods section). Two further factors of in-
fluence, optimizing this basis model, could be identified,
i. e. (iii) the octanol/water partition coefficient (logP), a
generally employed measure of lipophilicity, and (iv) the
spin density [σ(N)] at the nitrogen atom after radicaliza-
tion. A quadrufactorial linear model (equation 2) synthe-
sized out of these four parameters, all of them directly
1606 B. Moosmann et al.
Table 1 Overview of the Quantitative Antioxidant Cytoprotec-
tive Properties of the Aromatic Amines and Imines, and of
Some Control Compounds as Depicted in Figure 1.
EC50 value (µM)















The half-maximal effective concentrations (EC50 values) of the
compounds in two paradigms of antioxidant neuroprotection are
shown. HT22 cells were treated with 2 mM glutamate for 16 h,
and SK-N-MC cells were challenged with 160 µM hydrogen per-
oxide for the same period of time, applying the antioxidant com-
pounds concomitantly with the respective toxin. Cellular survival
was subsequently quantified as described in Materials and
Methods. The EC50 values were calculated from the results of ten
different concentrations of every compound, each concentration
measured at least in triplicate. Examples of cell survival graphs
from which the EC50 constants were determined are shown in
Figure 4. The potency of the aromatic compounds seems to be
independent of the cell biological experimental system, but
strongly linked to individual parameters of chemical structure.
Fig. 5 Spin Quenching by Iminostilbene.
Electron paramagnetic resonance spectra of N-tert-butyl-α-
phenylnitrone (PBN; 50 mM) after oxidation with tert-butyl hy-
droperoxide (t-BuOOH; 100 mM) in ethanol with or without imi-
nostilbene in different concentrations. (A) positive control, (B) is
above setting with 50 mM iminostilbene, (C) with 10 mM, (D) with
2 mM, (E) with 0.5 mM, and (F) with 0.1 mM iminostilbene. Even at
a 500-fold lower concentration, iminostilbene significantly sup-
presses PBN spin adduct formation under the employed strong-
ly prooxidant conditions (i. e. 100 mM t-BuOOH; 75 °C; 8 h). The
bar indicates 10 G.
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amenable to calculation, reaches a predictive potency of
97%. The model equations and their statistical evaluation
are given in the Materials and Methods section. A visual-
ization of the predictive potency of both models is de-
picted in Figure 6, comparing the directly measured cyto-
protective ln(EC50) values, as derived from Table 1, with
ln(EC50) values calculated according to the quantum
chemical models. Especially the quadrufactorial model
seems to represent a linearization of strong predictive
value.
Discussion
Comparing the structures of the aromatic amines and
imines shown in Figure 1 with their quantitative protective
potencies listed in Table 1, some structural prerequisites
of cytoprotective action can be derived. These can be di-
vided into mandatory, essential structural moieties, and
factors that enhance antioxidant activity. The basic build-
ing block of a cytoprotective aromatic amine is the aniline
structure, and its cytoprotective function increases with
increasing lipophilicity, as seen from the comparison of 4-
dodecylaniline with 4-butylaniline. The nature of the aro-
matic system bearing the nitrogen atom is the main de-
terminant to enhance antioxidant activity. In this respect,
as a single aromatic system naphthalene is not superior
to benzene, but two aromatic moieties attached to the
central nitrogen atom are generally superior to a single
aromatic system. Further increases in antioxidative po-
tency are produced by a bridging of the two aromatic
rings (iminodibenzyl versus diphenylamine), an additional
mesomeric coupling of the rings (iminostilbene versus
iminodibenzyl), or a bridging of the rings with a het-
eroatom with lone electron pairs, such as oxygen or sul-
fur (phenoxazine and phenothiazine versus iminodiben-
zyl). In general, imines are more potent than amines.
The presence of at least one single NH-bond is the
other essential prerequisite for antioxidant action: 1-
naphthylamine as well as phenothiazine, being very dif-
ferent in antioxidant potency, become almost inefficient
upon methylation, i. e. the loss of their NH-bonds
(Figure 1 and Table 1). These findings, concerning the
aromatic system and the NH-bond, together with the bio-
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Table 2 Calculated Molecular Parameters of the Antioxidant Compounds That Influ-
ence Their Cytoprotective Potential.
(A) (B) (C) (D) (E)
Measured ∆Hf E(LUMOr) logP σ(N)
In(EC50/nM) [kcal/mol] [eV]
4-Butylaniline 8.853 40.56 0.3378 2.84 0.2519
1-Naphthylamine 8.294 39.50 – 0.2309 2.17 0.1742
4-Dodecylaniline 6.856 40.10 0.3349 6.48 0.2522
Diphenylamine 6.551 41.80 – 0.3666 3.46 0.2997
(1-Naphthyl)-phenylamine 5.991 35.86 – 0.5024 4.58 0.1975
Iminodibenzyl 5.703 36.29 – 0.3430 3.94 0.2888
(2-Naphthyl)-phenylamine 5.164 38.58 – 0.6994 4.58 0.2923
Iminostilbene 4.317 35.46 – 1.2028 3.63 0.2405
Phenoxazine 3.806 31.41 – 0.6545 1.98 0.2890
Phenothiazine 2.995 24.99 – 0.7777 3.34 0.1863
The measured neuroprotective potencies of the compounds are expressed in column (A)
as the logarithm of the mean of the two EC50 values of neuroprotection listed in Table 1
(normalized to nanomolar units). Column (B) shows the difference of the calculated heats
of formation (∆Hf; kcal/mol) of a parent compound and its radical form, the latter result-
ing from the abstraction of the nitrogen-bound hydrogen atom. Column (C) is the energy
(eV) of the respective radical’s lowest unoccupied molecular orbital (LUMOr). Column (D)
gives the octanol/water partition coefficient (logP) of each compound, and column (E) in-
dicates the spin density [σ(N)] at the nitrogen atom after radicalization by hydrogen ab-
straction.
Fig. 6 Analysis of the Calculated Quantitative Models for Cyto-
protective Antioxidant Action.
The measured ln(EC50) values are plotted against values calcu-
lated according to two predictive quantitative models of antioxi-
dant action. Open circles () represent the bifactorial model
which only employs ∆Hf and E(LUMOr) as determinants of the
cytoprotective effect (equation 1); filled circles () represent the
quadrufactorial model of equation 2, which additionally takes
into consideration logP and σ(N). Both models can directly pre-
dict the protective behaviour of an antioxidant molecule in neu-
ronal cell cultures.
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chemical assays in Figure 4 and the ESR measurements
in Figure 5 imply that the homolytic dissociation of the
NH-bond, leading to an amine or imine radical, compris-
es the basic mechanism of cytoprotective action. On the
basis of this hypothesis, and from the analogy to pheno-
lic antioxidants, the quantum mechanical calculations
summarized in Table 2 were performed.
A quantitative structure-activity relationship model
was developed which employs exclusively intelligible pa-
rameters of molecular architecture with regard to the
above radicalization hypothesis. This model reaches an
adjusted correlation coefficient of 0.969, which indicates
that the essential physical properties required for antiox-
idant cytoprotective activity have been identified, and
which strongly implies that the above hypothesis is in-
deed justified. It is remarkable that such a reliable corre-
lation could be drawn directly between in silico data and
measured cell biological effects of pathological rele-
vance. With phenolic antioxidants similar approaches
have been followed (Burton et al., 1980; van Acker et al.,
1993), but they have generally linked calculated proper-
ties only to surrogate markers of antioxidant activity, such
as the redox potential, or the reactivity of the compounds
in model reactions of limited biological relevance (van
Acker et al., 1996; Lien et al., 1999; Halliwell, 2000).
The chemical calculations also provide some quantita-
tive insight into the structural enhancers of antioxidant
activity. While the difference of the heats of formation,
∆Hf, is especially reduced in the imine antioxidants,
which finally seems to determine their superior antioxi-
dant activity, a low LUMOr energy level apparently mir-
rors the aromatic stabilization of the nitrogen-based rad-
ical. The spin density at the nitrogen atom is, however,
not directly correlated to antioxidant activity (r2 = 0.007),
as deducible from the values in Table 2 or its unexpected
negative contribution in equation 2, but it seems to cor-
rect overrepresented influences of ∆Hf or E(LUMOr) in
this equation. The fourth property, lipophilicity, as repre-
sented by the logP value, further refines the model pre-
sented.
It has already been shown that positively charged am-
monium groups impede antioxidant action in derivatives
of phenothiazine (Yu et al., 1992); nevertheless lipophilic-
ity has to be considered with care, as far as drug design
is concerned. Neuroprotective agents should be able to
penetrate the blood-brain barrier effectively, but very
lipophilic compounds with long alkyl chain membrane
anchors are usually excluded from passively entering the
brain (Seelig et al., 1994; Moosmann and Behl, 2000b).
Therefore, this factor might be overestimated in cell bio-
logical considerations.
Finally, the question arises of how to judge the poten-
cy of the aromatic imines with respect to other classes of
antioxidants, keeping in mind the EC50 values of 20 to 75
nM for the three bridged and mesomerically coupled bis-
arylimines. We and others have tested many different an-
tioxidants in identical cell biological systems to those de-
scribed here, e. g. glutamate toxicity in HT22 cells, and
we have found that among twenty natural or synthetic
monophenolic compounds 4-dodecylphenol had the
highest potency, with an EC50 value of 2 µM (Moosmann
et al., 1997; Moosmann and Behl, 1999). Ishige et al.
(2001) have recently assayed approximately 25 polyphe-
nolic flavonoid compounds in the same setting and found
that the best structure, baicalein, exhibited an EC50 value
of 1 µM, while most of the structures had no effect at all.
The value for quercetin, which we have included for com-
parison (Table 1), was 3 µM. Recently, we have shown that
diverse other types of antioxidants are either completely
ineffective (such as bilirubin, β-carotene, and some
lazaroids) or rather weak (thiol compounds) in protecting
neuronal cells from oxidative stress (Moosmann and
Behl, 2000a). Since the best phenolic antioxidants are
therefore characterized by EC50 values that are two or-
ders of magnitude higher than those of the best bis-
arylimines, the conclusion can be drawn that phenols
seem to be generally inferior to imines with respect to an-
tioxidant neuroprotection. In addition, the presented bis-
arylimines do not appear to constitute the best imagina-
ble molecules yet, with respect to the calculated
physico-chemical parameters shown in Table 2. We
therefore assume that this structural class of compounds
is clearly amenable to optimization by further rational
chemical substitution of the aromatic rings of the shown
lead structures, for example according to equation 2. The
presented lead molecules themselves might have further
advantages such as their relatively low molecular weight,
e. g. as compared to flavonoids, and their relatively high
lipophilicity combined with an estimated high critical mi-
cellar concentration and a comparably low cross-sec-
tional area at the lipid/water interface. These might all be
favorable aspects of efficient blood-brain barrier perme-
ation (Seelig et al., 1994; Fischer et al., 1998).
The cellular models employed to test the compounds
for antioxidant neuroprotective effects are of high rele-
vance for the phenomena occurring in neurodegenera-
tive disease. Hydrogen peroxide (Figures 3 and 4) is a
known toxin and inducer of apoptosis in Alzheimer’s dis-
ease (Behl et al., 1994), and it is involved in nigral degen-
eration in Parkinson’s disease (Ebadi et al., 1996). Super-
oxide dismutase (SOD)/catalase mimetics with a higher
catalase activity but identical SOD activity are significant-
ly more effective in rat models of focal ischemia (Baker et
al., 1998), pointing toward an important role of hydrogen
peroxide in ischemic neuronal cell death. Down’s syn-
drome neurons have been described to exhibit elevated
intracellular levels of peroxides and an increased degree
of lipid peroxidation (Busciglio and Yankner, 1995). Intra-
cellular glutathione depletion (Figures 2 and 4) is a major
adverse consequence of cellular exposure to cytotoxic
agents, and an early specific biochemical event in inci-
dental Lewy body disease and Parkinson’s disease (Gu et
al., 1998; Sies, 1999). Excitotoxicity due to increased lev-
els of the neurotransmitter glutamate constitutes a gen-
eral hallmark of many neurodegenerative diseases, even
if the mechanisms of cell death may vary among neuronal
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populations (Sattler and Tymianski, 2000). The presented
cell biological data for the antioxidant neuroprotective ef-
fects of aromatic amines and imines might therefore be of
high relevance to the situation in vivo and to the treatment
of neurological disease.
In summary, we have investigated the neuroprotective ef-
fects of aromatic amine and imine compounds, employ-
ing diverse models of oxidative neuronal cell death which
have been considered to be relevant to the oxidative
pathogenetic processes occurring in several neurode-
generative diseases. We found that this class of lead
structures contains examples of superior efficacy to pro-
tect neurons from oxidative apoptosis. The neuroprotec-
tive effects seem to occur under a variety of very different
conditions of oxidative stress, but they can nevertheless
be intimately linked to predictable chemical properties of
the compounds. These results may open new avenues
for neuroprotective drug design.
Materials and Methods
Chemicals
Chemicals and biochemicals were purchased from Sigma-
Aldrich at the highest grade available. The antioxidant chemicals
were from Sigma-Aldrich or from this supplier’s Library of Rare
Chemicals. In general, a purity of 97 – 99% was indicated. 
4-Dodecylphenol was employed as a mixture of homologs
(80%). N-Methyl-phenothiazine (98%) was recrystallized twice
(ethanol:water 1:1; methanol:water 1:1) to remove potential con-
taminations, and was afterwards found to be pure according to
analytical TLC.
Cell Culture
All media, sera, and supplements for cell culture were obtained
from Gibco-BRL. Glutamate-sensitive murine hippocampal neu-
rons (HT22) were a kind gift from P. Maher (The Scripps Research
Institute, La Jolla, USA). Human neuroblastoma cells (SK-N-MC)
and murine clonal fibroblasts (NIH3T3) were from the American
Type Culture Collection. Clonal cell cultures were grown under
standard conditions [Dulbecco’s Modified Eagle Medium
(DMEM) supplemented with 10% fetal calf serum (FCS) under
5% CO2 atmosphere in a humidified 37 °C incubator].
Cerebellar Primary Neurons
Newborn Sprague-Dawley (Charles River) rats were decapitated
on post-natal day 3 to prepare dissociated neuronal cell cultures
from cerebellum. The cerebella were cut into several pieces and
were then incubated in Dulbecco’s phosphate-buffered saline
(D-PBS) containing 0.05% trypsin and 0.02% EDTA for 20 min at
room temperature. Subsequently the tissue pieces were trans-
ferred to Hank’s balanced salt solution (HBSS) supplemented
with 10% fetal calf serum (FCS). The cells were dissociated by
careful pipetting through a serological pipette, and remaining
undissociated pieces were removed by filtration through a 50 µm
nybolt mesh (Eckert). After centrifugation (200 g, 4 min), the cells
were resuspended in Minimal Essential Medium (MEM) supple-
mented with 10% FCS and plated at a density of 50 000 cells per
well in 96-well plates. The plates had been precoated with a
0.01 mg/ml poly-L-lysine solution for 4 h (molecular weight
range 70 – 150 kDa). After 36 h in culture, the cells were trans-
ferred to serum-free conditions with the final culture medium
MEM:F12 1:1 including N2 supplements, modified to finally con-
tain 0.5 nM triiodothyronine and 5 g/l glucose. Experiments were
performed beginning 24 h after the change to serum-free condi-
tions.
Organotypic Hippocampal Slice Culture
Eight to ten day old Sprague-Dawley rats were decapitated, the
brains were removed and transferred to cold Minimal Essential
Medium (MEM). A tissue chopper was used to cut the hip-
pocampi into 400 µm slices, which were placed on sterile,
porous 0.4 nm membranes (Millipore). The membranes were
then transferred to tissue culture plates covered with culture
medium (MEM supplemented with 1% FCS). The culture medi-
um was changed two times per week. Slice cultures were used
for experiments after 7 days in vitro.
Cell Viability
Cell viability experiments were generally done employing two
measuring principles: colorimetric assays of metabolic activity
[using the tetrazole 3-(4,5-dimethylthiazol-2-yl-)-2,5-diphenylte-
trazolium bromide, MTT], and cell counts after staining for cell
membrane permeabilized cells (employing the fluorescent DNA
intercalator propidium iodide, PI, and the azo-dye trypan blue,
which leaves intact cells unstained as viewed by phase contrast
microscopy). No significant discrepancies between the different
methods to determine cell viability, with either clonal cell lines or
primary neurons, could be observed.
For individual cell viability experiments, HT22 cells were plat-
ed at a density of 4000 cells per well (SK-N-MC cells: 20 000
cells per well; NIH3T3 cells: 10 000 cells per well) in 96-well cul-
ture dishes for 24 h. Then the cytotoxins were added in the indi-
cated concentrations. After the incubation, 0.5 mg/ml of the
MTT reagent were applied to the cells for 2 – 8 h, after which the
cells were lysed by the addition of 1 volume of solubilization so-
lution [40% dimethylformamide (DMF), 10% sodium dodecyl
sulfate (SDS), pH 4.0 with acetic acid]. One day later, the plates
were read with a Dynatech photometer at 550 nm. For the pro-
pidium iodide measurements, the cells were incubated with 10
µg/ml of the dye for 10 min. After two washes with DMEM, the
cell cultures were photographed employing phase contrast ver-
sus fluorescence optics (filter cut-off at 540 nm). Quantification
of cell survival was done by calculating the ratio of live/dead
cells per culture plate area on the photographs.
As neurotoxins, L-glutamate, hydrogen peroxide (H2O2), tert-
butyl hydroperoxide (t-BuOOH), and S-butylhomocysteine sul-
foximine [L-buthionine-(S,R)-sulfoximine, BSO] were employed
in the indicated concentrations, generally leading to a nearly
complete loss of cell viability with the plating densities and incu-
bation times used. All of these oxidative toxins were compared
in HT22 cells, while in the other cell systems a representative se-
lection of them would be applied. HT22 cells are a very well-es-
tablished, reproducible model to investigate neuronal cell death
(Tan et al., 1998). The antioxidants were generally added con-
comitantly with the respective toxins without preincubation as
100- or 200-fold ethanolic solutions. For the kinetic experi-
ments, antioxidants were added at the indicated time points af-
ter the addition of the toxin.
In the hippocampal slice culture experiments, propidium io-
dide (PI) was added to the cultures at a concentration of 5 µg/ml
for 4 – 6 h. PI is a fluorescent DNA label which selectively enters
slice culture cells with permeable or lysed cell membrane. After
the incubation, the slices were washed with fresh culture medi-
um to remove excess PI. The cultures were then examined with
an Olympus fluorescence microscope; PI fluorescence was
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evaluated using an excitation filter set at 470 – 490 nm and a bar-
rier filter set at 515 – 550 nm.
For the incubation of the slice cultures with hydrogen perox-
ide, H2O2 (500 µM) was added to the cultures every 24 h for a to-
tal of 72 h by exchanging the culture medium. The antioxidants
were added to the cultures from 10– 2 M stock solutions in
ethanol, and these or ethanol alone were analogously added to
the culture medium every 24 h for a total of 72 h after the ex-
change of the medium.
Peroxide Accumulation
Neuronal HT22 cells seeded in 96-well dishes as described
above were treated with buthionine sulfoximine (BSO; 1 mM) for
8 h and were afterwards loaded with 20 µM dichlorofluorescin di-
acetate (DCFA) for 10 min. DCFA is converted by intracellular hy-
drolysis to a fluorescent probe for peroxides and other oxidizing
species. The DFCA-containing medium was removed, and the
cells were covered with fresh DMEM after a washing step with
the same medium. Cell-trapped fluorescence was measured
with a Wallac fluorescence plate reader employing a 485 nm ex-
citation filter and a 535 nm emission filter. For the experiments
with delayed addition of the antioxidants, cells were treated with
glutamate (2 mM) for 8 h, then the antioxidants were added for a
further incubation of 2 h. Afterwards, DCFA was added as de-
scribed above.
Brain Lipid Peroxidation
Dissected cerebral cortex of adult Sprague-Dawley rats was ho-
mogenized in three volumes of degassed nonreducing lipid
buffer (20 mM TRIS pH 7.4, 1 mM MgCl2, 5 mM KCl) with a Kontes
glass homogenizer. This and all subsequent steps were per-
formed at 4 °C. After centrifugation (3000 g, 5 min), the pellet
was solubilized by sonication in lipid buffer supplemented with
0.5 M NaCl, incubated for 30 min, and centrifuged again (100 000
g, 20 min). This step was repeated and followed by three analo-
gous washing steps with water instead of lipid buffer. The result-
ing pellet was resuspended in water at a concentration of 5
mg/ml protein and rapidly frozen at – 80 °C.
To determine the degree of lipid peroxidation with or without
the cytoprotectants, low-level chemiluminescence was meas-
ured as an indicator of peroxidation reactions in progress. The
rat brain membrane preparation was diluted with PBS to a con-
centration of 0.6 mg/ml protein and sonicated. Then the cyto-
protective compounds were added to the aliquots as 1000-fold
stock solutions in ethanol. The oxidative chain reaction was ini-
tiated by addition of 50 µM ascorbate and transfer to 37 °C. Six
hours later, single photon counting was performed for 1 min with
a Beckman scintillation counter, after decay of static electricity.
ESR Spectroscopy
Electron spin resonance spectra were measured on a Bruker
ER-200 D-SRC spectrometer (TE 102 cavity), with a modulation
frequency of 100 kHz, modulation amplitude of 0.8 G, sweep
width of 100 G, center field of 3360 G, and microwave power of
5 mW. Receiver gain was 5 × 105. Samples were prepared by co-
incubation of the spin trap N-tert-butyl-α-phenylnitrone (PBN;
50 mM), the respective concentration of the aromatic imine, and
the radical initiator tert-butyl hydroperoxide (t-BuOOH; 100 mM)
in pure ethanol at a temperature of 75 °C for 8 h. The samples
were then transferred to glass capillaries with an internal diame-
ter of 0.9 mm. The typical sample volume was 40 – 50 µl. All
spectra were acquired at room temperature.
Computational Chemistry
Molecular mechanics and semi-empirical quantum chemical
calculations were performed employing the Chem3D software
package. Geometry optimizations were done on the basis of a
modified Allinger’s MM2 force field routine. The semi-empirical
MOPAC AM1 Hamiltonian was chosen for the subsequent cal-
culation of the electronic levels (LUMO), the heats of formation
(Hf), and the spin densities (σ). The energy minimizations were
done to a minimum RMS gradient of 0.1. A microstate-improved,
closed shell RHF approach was employed for the calculations,
as implemented in MOPAC. All molecules, the parent com-
pounds and the radicals were defined to be in ground state. For
the determination of the octanol/water partition coefficients
(logP), the Best Estimate method was used, which selects the lit-
erature fragmentation with the lowest standard deviation of esti-
mate for the molecule of interest.
Employing ∆Hf and E(LUMOr) to synthesize a bifactorial mod-
el for the compounds’ antioxidant action, led to equation 1:
ln(EC50) = – 0.821 + 0.204 × ∆Hf + 1.888 × E(LUMOr) (eq 1)
[number of data points n = 10; adjusted correlation coefficient r2
= 0.787; standard error of estimate s = 0.865 (p = 0.002); con-
stant = – 0.821 ± 2.698 (p = 0.770); coefficient1 = 0.204 ± 0.0687
(p = 0.021); coefficient2 = 1.888 ± 0.726 (p = 0.035)].
Expanding this model by including logP and σ(N), to build a
quadrufactorial model, resulted in equation 2:
ln(EC50) = 1.109 + 0.271 × ∆Hf + 1.781 × E(LUMOr) –
0.340 × logP – 12,687 × σ(N) (eq 2)
[number of data points n = 10; adjusted correlation coefficient r2
= 0.969; standard error of estimate s = 0.331 (p < 0.001); con-
stant = 1.109 ± 1.074 (p = 0.349); coefficient1 = 0.271 ± 0.0285 (p
< 0.001); coefficient2 = 1.781 ± 0.286 (p = 0.002); coefficient3 =
– 0.340 ± 0.0877 (p = 0.012); coefficient4 = – 12.687 ± 2.538 (p =
0.004)].
In both models, the respective variables contributed to the
equations independently, as indicated by the p-values given in
brackets. The cross-correlation matrix revealed low interde-
pendence of the four calculated physico-chemical parameters:
∆Hf vs E(LUMOr): r2 = 0.555; ∆Hf vs logP: r2 = 0.099; ∆Hf vs σ(N):
r2 = 0.363; E(LUMOr) vs logP: r2 = 0.152; E(LUMOr) vs σ(N): r2 =
0.192; logP vs σ(N): r2 = 0.067.
All statistical analyses and linear regression calculations were
performed using the SigmaStat and SPSS software packages.
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